Cancer Therapy & Research Center UT Health Science Center SC-4

San Antonio, Texas 78229

0 studies enrolling now · 1 studies all time

What they study most

ALK-positive Advanced Tumors

Studies at this site

• A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors — Completed